Informações de Becton Dickinson and Co | Histórico, dados financeiros e desempenho de mercado

Informações de Becton Dickinson and Co Empresa

Informações da empresa

Código da empresaBDX

Nome da EmpresaBecton Dickinson and Co

Data de listagemSep 25, 1963

Fundado em1906

CEOMr. Thomas E. Polen

Funcionários74000

Tipo de TítulosOrdinary Share

Fim do ano fiscalSep 25

EndereçoOne Becton Drive

CidadeFRANKLIN LAKES

Bolsa de ValoresNYSE Consolidated

PaísUnited States of America

Código postal07417-1880

Telefone12018476800

Sitehttps://www.bd.com/

Código da empresaBDX

Data de listagemSep 25, 1963

Fundado em1906

Executivos da Empresa

Nome

Nome/Posição

Posição

Ações Detidas

Variação

Mr. Richard (Rick) Byrd

Executive Vice President, President - Interventional Segment

757.04K

+19.29K%

Mr. Timothy M. (Tim) Ring

Independent Director

59.86K

+1.58%

Ms. Shana Carol Neal

Chief People Officer, Executive Vice President

48.90K

-3.12%

Ms. Catherine M. (Cathy) Burzik

Independent Director

14.80K

+6.70%

Mr. Roland Goette

Executive Vice President, President - EMEA

14.20K

-8.25%

Mr. Antoine C. Ezell

Executive Vice President, President, North America, Chief Marketing Officer

11.97K

+28.43%

Mr. Michael Feld

Executive Vice President, President - Life Sciences

9.19K

+38.45%

Mr. Robert Andrew (Andy) Eckert

Independent Director

9.13K

+11.33%

Ms. Michelle Quinn

Executive Vice President, General Counsel

6.92K

+39.79%

Dr. Carrie L. Byington, M.D.

Independent Director

5.24K

+21.54%

Ver Mais

Nome

Nome/Posição

Posição

Ações Detidas

Variação

Mr. Richard (Rick) Byrd

Executive Vice President, President - Interventional Segment

757.04K

+19.29K%

Mr. Timothy M. (Tim) Ring

Independent Director

59.86K

+1.58%

Ms. Shana Carol Neal

Chief People Officer, Executive Vice President

48.90K

-3.12%

Ms. Catherine M. (Cathy) Burzik

Independent Director

14.80K

+6.70%

Mr. Roland Goette

Executive Vice President, President - EMEA

14.20K

-8.25%

Mr. Antoine C. Ezell

Executive Vice President, President, North America, Chief Marketing Officer

11.97K

+28.43%

Detalhamento da Receita

Moeda: USDTempo de atualização: qua, 5 de mar

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2021

FY2020

FY2019

Por EmpresaUSD

Nome

Receita

Proporção

Medication Delivery Solutions

1.12B

21.74%

Medication Management Solutions

801.00M

15.49%

Integrated Diagnostic Solutions

474.00M

9.17%

Peripheral Intervention

473.00M

9.15%

Specimen Management

462.00M

8.93%

Other

1.83B

35.48%

Por RegiãoUSD

Nome

Receita

Proporção

United States

3.07B

59.57%

International

2.08B

40.42%

Por Empresa

Por Região

Por EmpresaUSD

Nome

Receita

Proporção

Medication Delivery Solutions

1.12B

21.74%

Medication Management Solutions

801.00M

15.49%

Integrated Diagnostic Solutions

474.00M

9.17%

Peripheral Intervention

473.00M

9.15%

Specimen Management

462.00M

8.93%

Other

1.83B

35.48%

Acionista

Tempo de atualização: sex, 21 de fev

Estatísticas do Acionista

Tipo

Estatísticas do Acionista

Acionista

Proporção

The Vanguard Group, Inc.

9.26%

BlackRock Institutional Trust Company, N.A.

5.15%

State Street Global Advisors (US)

4.90%

T. Rowe Price Investment Management, Inc.

4.22%

T. Rowe Price Associates, Inc.

4.15%

Other

72.28%

Estatísticas do Acionista

Acionista

Proporção

The Vanguard Group, Inc.

9.26%

BlackRock Institutional Trust Company, N.A.

5.15%

State Street Global Advisors (US)

4.90%

T. Rowe Price Investment Management, Inc.

4.22%

T. Rowe Price Associates, Inc.

4.15%

Other

72.28%

Tipo

Acionista

Proporção

Investment Advisor/Hedge Fund

41.50%

Investment Advisor

41.05%

Pension Fund

2.87%

Hedge Fund

2.49%

Research Firm

2.45%

Bank and Trust

1.65%

Sovereign Wealth Fund

1.23%

Individual Investor

0.56%

Insurance Company

0.28%

Other

5.86%

Instituição Participações

Tempo de atualização: dom, 19 de jan

Período do Relatório

Nº de instituições

Ações detidas

Proporção

Variação

2025Q1

2786

271.52M

94.56%

-4.48M

2024Q4

2874

271.53M

94.56%

-4.61M

2024Q3

2787

266.28M

92.14%

-3.20M

2024Q2

2782

261.00M

90.31%

-2.67M

2024Q1

2797

255.98M

88.58%

-10.13M

2023Q4

2783

259.38M

89.78%

-7.78M

2023Q3

2768

264.63M

91.23%

-591.86K

2023Q2

2787

263.28M

90.78%

-570.63K

2023Q1

2795

257.22M

90.56%

-8.75M

2022Q4

2831

255.71M

90.07%

-14.75M

Ver Mais

Atividade dos Acionistas

Nome

Ações detidas

Proporção

Variação

Chg %

Data

The Vanguard Group, Inc.

26.61M

9.26%

+188.34K

+0.71%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

14.81M

5.15%

+196.27K

+1.34%

Dec 31, 2024

State Street Global Advisors (US)

14.08M

4.9%

+134.35K

+0.96%

Dec 31, 2024

T. Rowe Price Investment Management, Inc.

12.12M

4.22%

+3.21M

+36.14%

Dec 31, 2024

T. Rowe Price Associates, Inc.

11.92M

4.15%

-1.15M

-8.83%

Dec 31, 2024

Geode Capital Management, L.L.C.

6.35M

2.21%

+66.02K

+1.05%

Dec 31, 2024

Generation Investment Management LLP

5.81M

2.02%

-139.25K

-2.33%

Dec 31, 2024

Morgan Stanley Investment Management Ltd. (UK)

5.69M

1.98%

-310.27K

-5.16%

Dec 31, 2024

MFS Investment Management

5.45M

1.89%

+708.73K

+14.93%

Dec 31, 2024

First Eagle Investment Management, L.L.C.

4.43M

1.54%

+1.05M

+31.36%

Dec 31, 2024

Ver Mais

ETFs Relacionados

Tempo de atualização: qui, 6 de mar

Nome

Proporção

iShares U.S. Medical Devices ETF

5.07%

T Rowe Price Capital Appreciation Equity ETF

3.49%

Brookstone Value Stock ETF

3.41%

ClearBridge Dividend Strategy ESG ETF

3.05%

Natixis Vaughan Nelson Select ETF

2.6%

American Century Focused Large Cap Value ETF

2.49%

Touchstone US Large Cap Focused ETF

2.39%

First Trust Indxx Medical Devices ETF

2.18%

ProShares MSCI Transformational Changes ETF

2.1%

SPDR S&P Health Care Equipment ETF

1.94%

Ver Mais

iShares U.S. Medical Devices ETF

Proporção5.07%

T Rowe Price Capital Appreciation Equity ETF

Proporção3.49%

Brookstone Value Stock ETF

Proporção3.41%

ClearBridge Dividend Strategy ESG ETF

Proporção3.05%

Natixis Vaughan Nelson Select ETF

Proporção2.6%

American Century Focused Large Cap Value ETF

Proporção2.49%

Touchstone US Large Cap Focused ETF

Proporção2.39%

First Trust Indxx Medical Devices ETF

Proporção2.18%

ProShares MSCI Transformational Changes ETF

Proporção2.1%

SPDR S&P Health Care Equipment ETF

Proporção1.94%

Dividendo

Um total de 5.33B USD foi distribuído em dividendos nos últimos 5 anos.

Data

Dividendo

Data de registro das ações

Data de pagamento

Data de ex-dividendo

Jan 28, 2025

BDX.NB Interim Cash Dividend of gross USD 1.04 paid on Mar 31, 2025 going ex on Mar 10, 2025

Mar 10, 2025

Mar 31, 2025

Mar 10, 2025

Nov 07, 2024

BDX.NB Final Cash Dividend of gross USD 1.04 paid on Dec 31, 2024 going ex on Dec 09, 2024

Dec 09, 2024

Dec 31, 2024

Dec 09, 2024

Jul 23, 2024

BDX.NB Interim Cash Dividend of gross USD 0.95 paid on Sep 30, 2024 going ex on Sep 09, 2024

Sep 09, 2024

Sep 30, 2024

Sep 09, 2024

Apr 30, 2024

BDX.NB Interim Cash Dividend of gross USD 0.95 paid on Jun 28, 2024 going ex on Jun 10, 2024

Jun 10, 2024

Jun 28, 2024

Jun 10, 2024

Jan 23, 2024

BDX.NB Interim Cash Dividend of gross USD 0.95 paid on Mar 29, 2024 going ex on Mar 07, 2024

Mar 08, 2024

Mar 29, 2024

Mar 07, 2024

Nov 09, 2023

BDX.NB Final Cash Dividend of gross USD 0.95 paid on Dec 29, 2023 going ex on Dec 07, 2023

Dec 08, 2023

Dec 29, 2023

Dec 07, 2023

Jul 25, 2023

BDX.NB Interim Cash Dividend of gross USD 0.91 paid on Sep 29, 2023 going ex on Sep 07, 2023

Sep 08, 2023

Sep 29, 2023

Sep 07, 2023

Apr 25, 2023

BDX.NB Interim Cash Dividend of gross USD 0.91 paid on Jun 30, 2023 going ex on Jun 08, 2023

Jun 09, 2023

Jun 30, 2023

Jun 08, 2023

Jan 24, 2023

BDX.NB Interim Cash Dividend of gross USD 0.91 paid on Mar 31, 2023 going ex on Mar 09, 2023

Mar 10, 2023

Mar 31, 2023

Mar 09, 2023

Nov 10, 2022

BDX.NB Final Cash Dividend of gross USD 0.91 paid on Dec 30, 2022 going ex on Dec 08, 2022

Dec 09, 2022

Dec 30, 2022

Dec 08, 2022

Ver Mais

Desdobramento de Ações

Data

Tipo

Proporção

Sem dados

Data

Tipo

Proporção

Sem dados

Becton Dickinson and Co

222.810USD

Becton Dickinson and Co

222.810

Visão Geral

Empresa